|
Glenmark Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
70979.51 Cr.
|
P/BV
|
6.46
|
Book Value (Rs.)
|
389.58
|
|
52 Week High/Low (Rs.)
|
2538/1793
|
FV/ML
|
1/1
|
P/E(X)
|
52.12
|
|
Bookclosure
|
31/08/2026
|
EPS (Rs.)
|
48.25
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 7648.28 | 9063.13 | 6522.04 | 6623.80 | 5569.65 |
| Other Operating Income | 22.93 | 248.18 | 121.72 | 54.18 | 0.00 |
| Total Income From Operations | 7671.20 | 9311.31 | 6643.76 | 6677.98 | 5569.65 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1506.49 | 1454.97 | 1541.14 | 1460.13 | 1411.81 |
| Purchase of Traded Goods | 1194.86 | 1201.79 | 762.90 | 803.11 | 623.91 |
| Increase/Decrease in Stocks | -233.97 | -376.67 | -130.85 | -83.08 | -7.94 |
| Employees Cost | 1728.84 | 1849.01 | 1525.06 | 1497.01 | 1453.99 |
| Depreciation | 302.36 | 271.13 | 247.94 | 238.07 | 298.41 |
| Other Expenses | 1842.63 | 2242.15 | 1784.26 | 1810.69 | 1792.18 |
| Total Expenses | 6341.21 | 6642.37 | 5730.45 | 5725.92 | 5572.37 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1329.99 | 2668.95 | 913.31 | 952.06 | -2.72 |
| Other Income | 233.55 | 227.07 | 42.81 | 70.91 | 818.58 |
| P/L Before Interest, Excpt. Items & Tax | 1563.54 | 2896.02 | 956.12 | 1022.97 | 815.86 |
| Interest | 84.04 | 124.69 | 119.01 | 88.06 | 282.90 |
| P/L Before Exceptional Items & Tax | 1479.50 | 2771.33 | 837.12 | 934.91 | 532.95 |
| Exceptional Items | -557.74 | -1708.35 | -372.82 | 0.00 | -523.51 |
| P/L Before Tax | 921.77 | 1062.98 | 464.30 | 934.91 | 9.45 |
| Tax | 217.22 | 405.57 | 111.89 | 240.18 | 1697.67 |
| P/L After Tax from Ordinary Activities | 704.55 | 657.41 | 352.42 | 694.72 | -1688.23 |
| Extra Ordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 143.14 |
| Net Profit/Loss For the Period | 704.55 | 657.41 | 352.42 | 694.72 | -1545.09 |
| Minority Interest | 0.08 | -0.18 | 0.20 | -0.24 | -24.57 |
| Net P/L After Minority Interest & Share Of Associates | 704.63 | 657.22 | 352.61 | 694.48 | -1569.66 |
| | | | | | |
| Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 24.97 | 23.29 | 12.49 | 24.61 | -54.75 |
| Diluted EPS (Rs.) | 24.97 | 23.28 | 12.49 | 24.61 | (59.82) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 24.97 | 23.29 | 12.49 | 24.61 | -54.75 |
| Diluted EPS (Rs.) | 24.97 | 23.28 | 12.50 | 24.61 | (55.62) |
| | | | | | |
| PBITOE Margin (%) | 17.33 | 28.66 | 13.74 | 14.25 | -0.04 |
| PBTE Margin (%) | 19.28 | 29.76 | 12.60 | 13.99 | 9.56 |
| PBT Margin (%) | 12.01 | 11.41 | 6.98 | 13.99 | 0.16 |
| PAT Margin (%) | 9.18 | 7.06 | 5.30 | 10.40 | -27.74 |
| PAT After MI And SOA Margin (%) | 9.18 | 7.05 | 5.30 | 10.39 | -28.18 |
